Mission
TO DEVELOP AND DRIVE ADOPTION OF PRACTICES THAT WILL INCREASE THE QUALITY AND EFFICIENCY OF CLINICAL TRIALS.THE SOCIETY COMPRISES MORE THAN 80 ORGANIZATIONS FROM ACROSS THE CLINICAL TRIAL ENTERPRISE. MEMBERS INCLUDE REPRESENTATIVES OF GOVERNMENT AGENCIES, INDUSTRY REPRESENTATIVES, PATIENT ADVOCACY GROUPS, PROFESSIONAL SOCIETIES, INVESTIGATOR GROUPS, ACADEMIC INSTITUTIONS, AND OTHER INTERESTED PARTIES.